Aimaiti Yasen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aimaiti Yasen has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Guoying Wang
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University
2 shared publications Jun Feng
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China
2 shared publicationsKai Li
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China
2 shared publications- Run-Bin Liang
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China
2 shared publications Yu-Hong Cai
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China
2 shared publicationsZhi-Hong Liao
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, Guangdong Province, China
2 shared publications
Latest Publications
- 11 March 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79 (6) , e868-e877
Management of anastomotic biliary stricture through utilizing percutaneous transhepatic cholangioscopy
- 11 March 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79 (6) , e868-e877
Management of anastomotic biliary stricture through utilizing percutaneous transhepatic cholangioscopy
- Open Access
- 5 May 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 119, 110253
Exosomes derived from TGF-β1-pretreated mesenchymal stem cells alleviate biliary ischemia–reperfusion injury through Jagged1/Notch1/SOX9 pathway
- 5 May 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 119, 110253
Open AccessExosomes derived from TGF-β1-pretreated mesenchymal stem cells alleviate biliary ischemia–reperfusion injury through Jagged1/Notch1/SOX9 pathway